According to Relay Therapeutics's latest financial reports the company has โฌ0.72 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | โฌ0.75 B | 10.66% |
2023-12-31 | โฌ0.67 B | -27.14% |
2022-12-31 | โฌ0.93 B | 10.08% |
2021-12-31 | โฌ0.84 B | 53.46% |
2020-12-31 | โฌ0.55 B | 73.56% |
2019-12-31 | โฌ0.31 B | -13.79% |
2018-12-31 | โฌ0.36 B |